Evaluation of salivary fluoride retention from a new high fluoride mouthrinse.
OBJECTIVE
To evaluate salivary fluoride retention from a new high fluoride daily use mouthrinse over a 120 min period.


METHODS
Sixteen subjects completed a randomised single-blind, four-treatment cross-over trial. Sensodyne® Pronamel® mouthrinse (A) contained 450 ppm fluoride; reference products were Colgate® Fluorigard® (B), Listerine® Total Care (C) and Listerine Softmint Sensation (D) containing 225, 100 and 0 ppm fluoride respectively. Salivary fluoride retention was monitored ex vivo after a single supervised use of test product (10 mL, 60 s). Samples were collected at 0, 1, 3, 5, 15, 30, 60 and 120 min post-rinse, generating fluoride clearance curves from which the area under the curve (AUC) was calculated. Differences in salivary fluoride concentrations for each product were analysed using ANCOVA at each time point using a 5% significance level, as well as lnAUC for the periods 0-120, 0-1, 1-15, 15-60 and 60-120 min. Pairwise comparisons between all treatment groups were performed.


RESULTS
Salivary fluoride levels for A-C peaked immediately following use. Fluoride levels were statistically significantly higher for A versus B-D (p≤ 0.004), linear dose responses were apparent. AUC(0-120) was statistically significantly greater for A than for B (p = 0.035), C (p< 0.0001) and D (p< 0.0001). Post-hoc comparisons of lnAUC for the remaining time domains showed fluoride retention from A was statistically significantly greater versus B-D (p< 0.0001).


CONCLUSIONS
Single-use treatment with the new mouthrinse containing 450 ppm fluoride resulted in statistically significantly higher salivary fluoride levels throughout the 120 min test period. Total fluoride retention (AUC(0-120)) was also statistically significantly greater versus comparator rinse treatments.
GlaxoSmithKline Consumer Healthcare, Weybridge, Surrey, UK.
Stephen C
SC
Mason
Soha
S
Shirodaria
Farzana
F
Sufi
Gareth D
GD
Rees
Dowen
D
Birkhed
D000704:Analysis of Variance; D019540:Area Under Curve; D018592:Cross-Over Studies; D004338:Drug Combinations; D005460:Fluorides, Topical / Q000032:analysis* / Q000493:pharmacokinetics; D006801:Humans; D009067:Mouthwashes / Q000737:chemistry* / Q000493:pharmacokinetics; D012463:Saliva / Q000737:chemistry* / Q000187:drug effects; D016037:Single-Blind Method; D018709:Statistics, Nonparametric; D013499:Surface Properties
D004338:Drug Combinations; D005460:Fluorides, Topical; D009067:Mouthwashes